About Cancer Research KI

Cancer Research KI serves as an overarching umbrella organisation for cancer research at Karolinska Institutet, conducted by more than 400 research groups at multiple campuses and departments. The overall goal is to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.

Background

In 2009 the Swedish Government designated in the Government Bill on Research Policy that 20 strategic research areas were to be prioritized; Cancer was one area. Cancer is represented nationally by three programmes: Cancer Research KI (formerly StratCan) at Karolinska Institutet, U-CAN (Universities of Uppsala & Umeå) and BioCare (Universities of Lund & Gothenburg).

Cancer as a strategic research area is motivated by the fact that cancer is one of the world's most common diseases and a major cause of death. In Sweden it is expected that cancer incidence will continue to rise and that cancer prevalence will double by 2030. New research strategies aiming at effective prevention and improved treatment are therefore urgently needed.

Organisation

Cancer Research KI was formed 2019 as the Strategic Research Programme in Cancer (StratCan) and the KICancer network joined forces. The programme is supported by the government through the strategic initiatives. More background information can be found here.

Executive Board Structure

CRKI Working Groups
Cancer Research KI Working Groups, 2026

Cancer research KI executive board members are holding positions at active cancers research departments involved in clinical, pre-clinical, and epidemiological research at the southern and northern campus of Karolinska Insitutet, some members hold dual affiliations both at the Karolinska Institutet and the Karolinska University Hospital as reflected in the present list of members. Two of the Cancer Research KI members are also members of the Board for the Cancer Theme at the Karolinska University Hospital. 

Reference Group to Cancer Research KI

The reference group should comprise of one representative from each KI department (full member), and one substitute that will attend meetings when the full member is not present, and on such occasions have full voting power. This group will be utilized by Cancer Research KI as one of the channels to distribute information related to the organisation's activities to all departments at KI. 

To read more about the organisation's reference group please click here.

Scientific Advisory Board 

A common Scientific Advisory Board (SAB) has been established for Cancer Research KI and the Karolinska Comprehensive Cancer Center (KCCC).

More information about the members of the board as well as their duties can be found here.

Executive Board Members

For information, please contact directly the Cancer Research KI office: cancerresearchki@ki.se

Elias Arnér, Ph.D., Professor

Elias Arnér, Ph.D., Professor

Director Cancer Research KI

Department of Medical Biochemistry and Biophysics (MBB), C2, (Northern Campus)

Marco Gerling, Dr. med., Group leader

Marco Gerling, Dr. med., Group leader

Co-Director Cancer Research KI

Department of Clinical Science, Intervention, and Technology (Southern Campus)

Oncologist

Anna Nilsson, M.D., Ph.D., Professor

Anna Nilsson, M.D., Ph.D., Professor

Co-Director Cancer Research KI

Department of Women's and Children's Health (KBH), K6, (Northern Campus)

Dhifaf Sarhan, Ph.D., Associate Professor (Docent)

Dhifaf Sarhan, Ph.D., Associate Professor (Docent)

Cancer Research KI Executive Board Member

Department of Laboratory Medicine (LabMed), H5, (Southern Campus)

Ninib Baryawno, Ph.D., Asst. Prof.

Ninib Baryawno, Ph.D., Asst. Prof.

Cancer Research KI Executive Board Member

Department of Women's and Children's Health (KBH), K6, (Northern Campus)

Margareta Wilhelm, Ph.D., Professor

Margareta Wilhelm, Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Microbiology, Tumor and Cell Biology (MTC), C1, (Northern Campus)

Andri Papakonstantinou, M.D., Ph.D.

Andri Papakonstantinou, M.D., Ph.D.

Cancer Research KI Executive Board Member

Department of Oncology-Pathology, K7 (Northern Campus)

Päivi Östling, Ph.D., Associate Professor

Päivi Östling, Ph.D., Associate Professor

Cancer Research KI Executive Board Member

Department of Oncology-Pathology (Onk-Pat), K7, (Northern Campus)

Simon Ekman, M.D., Ph.D., Professor

Simon Ekman, M.D., Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Oncology-Pathology, K7 (Northern Campus)

Matthias Löhr, M.D., Ph.D., Professor

Matthias Löhr, M.D., Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Clinical Science, Intervention and Technology (CLINTEC), H9, (Southern Campus)

 Renske Altena, M.D., Ph.D., Associate Professor (Docent)

Renske Altena, M.D., Ph.D., Associate Professor (Docent)

Cancer Research KI Executive Board Member

Department of Oncology-Pathology (OnkPat), K7, (Northern Campus)

Keith Humphreys, Ph.D., Professor

Keith Humphreys, Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Medical Epidemiology and Biostatistics (MEB), C8, (Northern Campus)

Joakim Dilner, M.D., Ph.D., Professor

Joakim Dilner, M.D., Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Clinical Science, Intervention and Technology (CLINTEC), H9, (Southern Campus)

Theodoros Foukakis, M.D., Ph.D., Professor

Theodoros Foukakis, M.D., Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Oncology-Pathology (Onk-Pat), K7, (Northern Campus)

Magnus Nilsson, M.D., Ph.D., Professor

Magnus Nilsson, M.D., Ph.D., Professor

Cancer Research KI Executive Board Member

Department of Clinical Science, Intervention and Technology (CLINTEC), H9, (Southern Campus)

Patrik Rossi, M.D., Ph.D.

Patrik Rossi, M.D., Ph.D.

Ex officio Cancer Research KI Executive Board Member

Acting Managing Director, Cancer Theme Karolinska University Hospital (Northern and Southern Campus)

Eva Jolly R.N., M.Sc.

Eva Jolly R.N., M.Sc.

Chief Coordinating Officer Karolinska Comprehensive Cancer Center
Lise-lott Eriksson

Lise-lott Eriksson

Patient Group Representative for Cancer Research KI
Lena Sharp R.N., Ph.D.

Lena Sharp R.N., Ph.D.

Adjunct Ex Officio Cancer Research KI Executive Board Member

Head of Regional Cancer Center Stockholm Gotland

João Pedro Alves-Lopes, Asst. Prof.

João Pedro Alves-Lopes, Asst. Prof.

Cancer Research KI Executive Board Junior Faculty representative

Department of Women's and Children's Health (KBH), K6, (Northern Campus)

Sara Abu Ajamieh

Sara Abu Ajamieh

Cancer Research KI Executive Board Ph.D. student representative

Department of Women's and Children's Health (KBH), K6, (Northern Campus)

Cancer Research KI Administration

Liselotte Bäckdahl, Ph.D.

Liselotte Bäckdahl, Ph.D.

Research Coordinator

Department of Medical Biochemistry and Biophysics (MBB), C2, (Northern Campus)

Pablo Marti Andres

Pablo Marti Andres

Research Coordinator
+46852486666

Department of Medical Biochemistry and Biophysics (MBB), C2, (Northern Campus)

Stefina Plamenova Milanova

Stefina Plamenova Milanova

Research Administrator
+46852486601

Department of Medical Biochemistry and Biophysics (MBB), C2, (Northern Campus)

Maya Molinari

Maya Molinari

Research Administrator

Executive Board Meeting Minutes

Cancer Research KI Executive Board Minutes - 2026

Cancer Research KI Executive Board Minutes - 2025

2026-08-20